|
MED8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.74719999998818E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.256300E-03 |
| Normal-vs-Stage2 |
8.438400E-02 |
| Normal-vs-Stage3 |
7.135100E-03 |
| Normal-vs-Stage4 |
1.53575999999322E-05 |
| Stage1-vs-Stage2 |
8.422400E-01 |
| Stage1-vs-Stage3 |
5.539800E-01 |
| Stage1-vs-Stage4 |
4.575500E-03 |
| Stage2-vs-Stage3 |
8.196400E-01 |
| Stage2-vs-Stage4 |
5.603700E-02 |
| Stage3-vs-Stage4 |
3.626100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.53779999998183E-06 |
| Normal-vs-AfricanAmerican |
4.476000E-01 |
| Normal-vs-Asian |
4.345700E-02 |
| Caucasian-vs-AfricanAmerican |
1.039560E-01 |
| Caucasian-vs-Asian |
6.520000E-02 |
| AfricanAmerican-vs-Asian |
1.256030E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.624600E-03 |
| Normal-vs-Female |
1.92729999737296E-08 |
| Male-vs-Female |
2.318900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.428000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.420900E-04 |
| Normal-vs-Age(61-80Yrs) |
6.39000000000056E-05 |
| Normal-vs-Age(81-100Yrs) |
1.439560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.274600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.295000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.723000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.852000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.609400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.563000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.318770E-03 |
| Normal-vs-Grade 2 |
3.980600E-04 |
| Normal-vs-Grade 3 |
9.421000E-03 |
| Normal-vs-Grade 4 |
2.93230000003586E-06 |
| Grade 1-vs-Grade 2 |
3.987600E-01 |
| Grade 1-vs-Grade 3 |
1.770170E-01 |
| Grade 1-vs-Grade 4 |
1.719220E-01 |
| Grade 2-vs-Grade 3 |
6.271600E-01 |
| Grade 2-vs-Grade 4 |
3.003000E-03 |
| Grade 3-vs-Grade 4 |
1.855690E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.62199999951407E-07 |
| Normal-vs-ccB subtype |
5.163500E-02 |
| ccA subtype-vs-ccB subtype |
1.361840E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.157430E-04 |
| Normal-vs-N1 |
3.222500E-03 |
| N0-vs-N1 |
6.355400E-03 |
|
|
